Gene: Gk (glycerol kinase) Rattus norvegicus
Analyze
Symbol:
Gk
Name:
glycerol kinase
Description:
Exhibits histone binding activity. Involved in response to cold and response to ethanol. Localizes to the mitochondrion and nucleus. Used to study familial hypercholesterolemia. Human ortholog(s) of this gene implicated in glycerol kinase deficiency. Orthologous to human GK (glycerol kinase); PARTICIPATES IN D-glycericacidemia pathway; familial lipoprotein lipase deficiency pathway; glycerol kinase deficiency pathway; INTERACTS WITH (R)-noradrenaline; 1-naphthyl isothiocyanate; 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)propanoic acid.
Type:
protein-coding
RefSeq Status:
VALIDATED
Also known as:
ASTP; ATP-stimulated glucocorticoid-receptor translocation promoter; ATP-stimulated glucocorticoid-receptor translocaton promoter; ATP:glycerol 3-phosphotransferase; glycerokinase; Gyk
Orthologs:
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
GK (glycerol kinase) RGD
RGD
Mus musculus (house mouse):
Gk (glycerol kinase) RGD
RGD
Chinchilla lanigera (long-tailed chinchilla):
Gk (glycerol kinase) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Pan paniscus (bonobo/pygmy chimpanzee):
GK (glycerol kinase) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Canis lupus familiaris (dog):
GK (glycerol kinase) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Gk (glycerol kinase) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Sus scrofa (pig):
GK (glycerol kinase) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Other homologs 2
Homo sapiens (human):
GK3P (glycerol kinase 3 pseudogene) HGNC
Ensembl, Inparanoid, Panther
Alliance orthologs 3
Mus musculus (house mouse):
Gk (glycerol kinase)
Alliance
DIOPT (Ensembl Compara, InParanoid, OMA, OrthoFinder, OrthoInspector, PANTHER)
Homo sapiens (human):
GK (glycerol kinase)
Alliance
DIOPT (Ensembl Compara, HGNC, InParanoid, OMA, OrthoFinder, PANTHER)
Danio rerio (zebrafish):
zgc:172295
Alliance
DIOPT (Ensembl Compara, OMA, OrthoFinder, OrthoInspector, PANTHER)
Saccharomyces cerevisiae (baker's yeast):
GUT1
Alliance
DIOPT (Ensembl Compara, InParanoid, OrthoFinder, OrthoInspector, PANTHER)
Drosophila melanogaster (fruit fly):
Gk1
Alliance
DIOPT (Ensembl Compara, InParanoid, OMA, OrthoFinder, OrthoInspector, PANTHER)
Caenorhabditis elegans (roundworm):
R11F4.1
Alliance
DIOPT (Ensembl Compara, InParanoid, OMA, OrthoFinder, OrthoInspector, PANTHER)
Latest Assembly:
Rnor_6.0 - RGSC Genome Assembly v6.0
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Rnor_6.0 X 54,227,291 - 54,303,897 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl X 54,227,397 - 54,303,864 (-) Ensembl Rnor_5.0 X 54,426,876 - 54,503,386 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 X 72,416,872 - 72,493,296 (-) NCBI RGSC3.4 rn4 RGSC3.4 RGSC_v3.1 X 72,491,081 - 72,566,588 (-) NCBI Celera X 50,789,241 - 50,865,448 (-) NCBI Celera Cytogenetic Map X q21 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Disease Annotations
Imported Annotations - ClinVar
autistic disorder ISO RGD:1344759 8554872 ClinVar Annotator: match by term: Autistic disorder of childhood onset ClinVar PMID:21681106 , PMID:30208311 Developmental Disabilities ISO RGD:1344759 8554872 ClinVar Annotator: match by term: Global developmental delay ClinVar PMID:25741868 epilepsy ISO RGD:1344759 8554872 ClinVar Annotator: match by term: Seizures ClinVar PMID:25741868 glycerol kinase deficiency ISO RGD:1344759 8554872 ClinVar Annotator: match by term: Deficiency of glycerol kinase ClinVar PMID:10737976 glycerol kinase deficiency ISO RGD:1344759 8554872 ClinVar Annotator: match by term: Deficiency of glycerol kinase ClinVar PMID:9719371 glycerol kinase deficiency ISO RGD:1344759 8554872 ClinVar Annotator: match by term: Deficiency of glycerol kinase ClinVar PMID:8651297 glycerol kinase deficiency ISO RGD:1344759 8554872 ClinVar Annotator: match by term: Deficiency of glycerol kinase ClinVar PMID:10736265 Neurodevelopmental Disorders ISO RGD:1344759 8554872 ClinVar Annotator: match by term: Neurodevelopmental disorder ClinVar PMID:25741868 syndromic X-linked intellectual disability Lubs type ISO RGD:1344759 8554872 ClinVar Annotator: match by term: MECP2 duplication syndrome ClinVar PMID:25741868 visual epilepsy ISO RGD:1344759 8554872 ClinVar Annotator: match by term: Seizures ClinVar PMID:25741868 X-linked adrenal hypoplasia congenita ISO RGD:1344759 8554872 ClinVar Annotator: match by term: Congenital adrenal hypoplasia, X-linked ClinVar
Imported Annotations - CTD
Experimental Liver Cirrhosis ISO RGD:1344759 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:25380136 Myocardial Ischemia ISO RGD:1344759 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:16214533 Imported Annotations - OMIM
glycerol kinase deficiency ISO RGD:1344759 7240710 OMIM
(R)-noradrenaline increases activity EXP 6480464 Norepinephrine results in increased activity of GK protein CTD PMID:12736183 (R)-noradrenaline increases expression EXP 6480464 Norepinephrine results in increased expression of GK mRNA CTD PMID:12736183 1,1-dichloroethene decreases expression ISO RGD:737445 6480464 vinylidene chloride results in decreased expression of GK mRNA CTD PMID:26682919 1-naphthyl isothiocyanate decreases expression EXP 6480464 1-Naphthylisothiocyanate results in decreased expression of GK mRNA CTD PMID:25380136 , PMID:30723492 17beta-estradiol affects expression ISO RGD:1344759 6480464 Estradiol affects the expression of GK mRNA CTD PMID:22574217 17beta-estradiol multiple interactions ISO RGD:1344759 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of GK mRNA CTD PMID:30165855 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)propanoic acid increases expression EXP 6480464 2 more ... CTD PMID:30920876 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1344759 6480464 Tetrachlorodibenzodioxin results in decreased expression of GK mRNA CTD PMID:20106945 , PMID:21632981 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:737445 6480464 Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to GK gene] CTD PMID:28213091 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of GK mRNA CTD PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:737445 6480464 Tetrachlorodibenzodioxin results in increased expression of GK mRNA CTD PMID:21496263 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:737445 6480464 Tetrachlorodibenzodioxin results in decreased expression of GK mRNA CTD PMID:16611356 , PMID:28213091 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:737445 6480464 Tetrachlorodibenzodioxin affects the expression of GK mRNA CTD PMID:24680724 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1344759 6480464 Tetrachlorodibenzodioxin results in increased expression of GK mRNA CTD PMID:21496263 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of GK mRNA CTD PMID:21346803 3,3',4,4',5-pentachlorobiphenyl decreases expression ISO RGD:737445 6480464 3 more ... CTD PMID:29216392 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:737445 6480464 [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of GK mRNA CTD PMID:23428407 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1344759 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of GK mRNA CTD PMID:28628672 4,4'-diaminodiphenylmethane decreases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of GK mRNA CTD PMID:25380136 4,4'-diaminodiphenylmethane increases expression ISO RGD:737445 6480464 4, 4'-diaminodiphenylmethane results in increased expression of GK mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol multiple interactions ISO RGD:1344759 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of GK mRNA CTD PMID:28628672 4-hydroxyphenyl retinamide increases expression ISO RGD:737445 6480464 Fenretinide results in increased expression of GK mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine decreases expression ISO RGD:1344759 6480464 Decitabine results in decreased expression of GK mRNA CTD PMID:19194470 8-bromo-3',5'-cyclic AMP increases expression ISO RGD:1344759 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of GK mRNA CTD PMID:22079614 aflatoxin B1 decreases methylation ISO RGD:1344759 6480464 Aflatoxin B1 results in decreased methylation of GK intron CTD PMID:30157460 alachlor affects expression EXP 6480464 alachlor affects the expression of GK mRNA CTD PMID:19425180 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of GK mRNA CTD PMID:16483693 antirheumatic drug decreases expression ISO RGD:1344759 6480464 Antirheumatic Agents results in decreased expression of GK mRNA CTD PMID:24449571 benzene increases expression ISO RGD:1344759 6480464 Benzene results in increased expression of GK mRNA CTD PMID:19162166 benzo[a]pyrene increases expression ISO RGD:737445 6480464 Benzo(a)pyrene results in increased expression of GK mRNA CTD PMID:19770486 , PMID:21715664 benzo[a]pyrene affects methylation ISO RGD:1344759 6480464 Benzo(a)pyrene affects the methylation of GK intron CTD PMID:30157460 benzo[a]pyrene increases expression ISO RGD:1344759 6480464 Benzo(a)pyrene results in increased expression of GK mRNA CTD PMID:26238291 benzo[a]pyrene diol epoxide I increases expression ISO RGD:1344759 6480464 7 more ... CTD PMID:20382639 benzo[e]pyrene increases methylation ISO RGD:1344759 6480464 benzo(e)pyrene results in increased methylation of GK promoter CTD PMID:30157460 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of GK mRNA CTD PMID:25181051 , PMID:30903817 bisphenol A increases expression ISO RGD:1344759 6480464 bisphenol A results in increased expression of GK mRNA CTD PMID:29275510 bisphenol A affects expression ISO RGD:1344759 6480464 bisphenol A affects the expression of GK mRNA CTD PMID:30903817 cadmium atom decreases expression ISO RGD:1344759 6480464 Cadmium results in decreased expression of GK mRNA CTD PMID:24376830 carbon nanotube increases expression ISO RGD:737445 6480464 Nanotubes, Carbon analog results in increased expression of GK mRNA, Nanotubes, Carbon results in increased expression of GK mRNA CTD PMID:25554681 choline multiple interactions ISO RGD:737445 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of GK gene CTD PMID:20938992 chromium(6+) affects expression ISO RGD:737445 6480464 chromium hexavalent ion affects the expression of GK mRNA CTD PMID:28472532 ciglitazone multiple interactions ISO RGD:1344759 6480464 [ciglitazone binds to PPARG protein alternative form] which results in increased expression of GK mRNA CTD PMID:16197558 ciguatoxin CTX1B affects expression ISO RGD:737445 6480464 Ciguatoxins affects the expression of GK mRNA CTD PMID:18353800 cisplatin increases expression ISO RGD:1344759 6480464 Cisplatin results in increased expression of GK mRNA CTD PMID:27392435 cisplatin multiple interactions ISO RGD:1344759 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of GK mRNA CTD PMID:27392435 clorgyline increases expression ISO RGD:1344759 6480464 Clorgyline results in increased expression of GK mRNA CTD PMID:19691856 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of GK mRNA CTD PMID:24386269 copper(II) sulfate increases expression ISO RGD:1344759 6480464 Copper Sulfate results in increased expression of GK mRNA CTD PMID:19549813 coumarin decreases expression EXP 6480464 coumarin results in decreased expression of GK mRNA CTD PMID:18480146 crocidolite asbestos affects expression ISO RGD:1344759 6480464 Asbestos, Crocidolite affects the expression of GK mRNA CTD PMID:25757056 cyclosporin A decreases expression ISO RGD:737445 6480464 Cyclosporine results in decreased expression of GK mRNA CTD PMID:19770486 cyclosporin A affects expression ISO RGD:1344759 6480464 Cyclosporine affects the expression of GK mRNA CTD PMID:25562108 cyclosporin A increases expression ISO RGD:1344759 6480464 Cyclosporine results in increased expression of GK mRNA CTD PMID:20106945 , PMID:21632981 dexamethasone multiple interactions ISO RGD:737445 6480464 [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of GK mRNA CTD PMID:23428407 dexamethasone multiple interactions ISO RGD:1344759 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of GK mRNA CTD PMID:28628672 dibutyl phthalate increases expression ISO RGD:737445 6480464 Dibutyl Phthalate results in increased expression of GK mRNA CTD PMID:21266533 dicrotophos decreases expression ISO RGD:1344759 6480464 dicrotophos results in decreased expression of GK mRNA CTD PMID:28302478 dobutamine increases activity EXP 6480464 Dobutamine results in increased activity of GK protein CTD PMID:12736183 dorsomorphin multiple interactions ISO RGD:1344759 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GK mRNA CTD PMID:27188386 fenofibrate increases expression ISO RGD:1344759 6480464 Fenofibrate results in increased expression of GK mRNA CTD PMID:25572481 finasteride increases expression EXP 6480464 Finasteride results in increased expression of GK mRNA CTD PMID:24136188 flavonoids decreases expression EXP 6480464 Flavonoids results in decreased expression of GK mRNA CTD PMID:18035473 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of GK mRNA CTD PMID:24793618 folic acid multiple interactions ISO RGD:737445 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of GK gene CTD PMID:20938992 glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of GK mRNA CTD PMID:24136188 glycerol multiple interactions EXP 6480464 1-butyrylglycerol promotes the reaction [[GK protein results in increased metabolism of Glycerol] which results in increased chemical synthesis of alpha-glycerophosphoric acid] more ... CTD PMID:9606984 glycerol 1-phosphate multiple interactions EXP 6480464 1-butyrylglycerol promotes the reaction [[GK protein results in increased metabolism of Glycerol] which results in increased chemical synthesis of alpha-glycerophosphoric acid] more ... CTD PMID:9606984 hydroquinone increases expression ISO RGD:1344759 6480464 hydroquinone results in increased expression of GK mRNA CTD PMID:31256213 indometacin affects expression ISO RGD:737445 6480464 Indomethacin affects the expression of GK mRNA CTD PMID:17546600 indometacin multiple interactions ISO RGD:1344759 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of GK mRNA CTD PMID:28628672 irinotecan decreases expression ISO RGD:1344759 6480464 Irinotecan analog results in decreased expression of GK mRNA CTD PMID:18927307 isoprenaline increases activity EXP 6480464 Isoproterenol results in increased activity of GK protein CTD PMID:12736183 isotretinoin decreases expression ISO RGD:1344759 6480464 Isotretinoin results in decreased expression of GK mRNA CTD PMID:20436886 L-methionine multiple interactions ISO RGD:737445 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of GK gene CTD PMID:20938992 lead diacetate increases expression EXP 6480464 lead acetate results in increased expression of GK mRNA CTD PMID:11578147 lovastatin multiple interactions ISO RGD:737445 6480464 [Dietary Fats co-treated with Lovastatin] affects the expression of GK mRNA CTD PMID:29852127 malathion multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Malathion results in increased activity of GK protein] CTD PMID:25449180 malathion increases activity EXP 6480464 Malathion results in increased activity of GK protein CTD PMID:25449180 methapyrilene increases methylation ISO RGD:1344759 6480464 Methapyrilene results in increased methylation of GK promoter CTD PMID:30157460 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of GK mRNA CTD PMID:30467583 methyl methanesulfonate increases expression ISO RGD:1344759 6480464 Methyl Methanesulfonate results in increased expression of GK mRNA CTD PMID:23649840 methylmercury chloride decreases expression ISO RGD:1344759 6480464 methylmercuric chloride results in decreased expression of GK mRNA CTD PMID:28001369 N-acetyl-L-cysteine multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Malathion results in increased activity of GK protein] CTD PMID:25449180 N-nitrosodiethylamine multiple interactions ISO RGD:737445 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of GK mRNA CTD PMID:24535843 N-nitrosodimethylamine decreases expression EXP 6480464 Dimethylnitrosamine results in decreased expression of GK mRNA CTD PMID:25380136 N-nitrosomorpholine increases expression EXP 6480464 N-nitrosomorpholine results in increased expression of GK protein CTD PMID:19716841 nimesulide decreases expression EXP 6480464 nimesulide results in decreased expression of GK mRNA CTD PMID:24136188 obeticholic acid decreases expression ISO RGD:1344759 6480464 obeticholic acid results in decreased expression of GK mRNA CTD PMID:27939613 ochratoxin A decreases expression EXP 6480464 ochratoxin A results in decreased expression of GK mRNA CTD PMID:12700408 paracetamol decreases expression ISO RGD:1344759 6480464 Acetaminophen results in decreased expression of GK mRNA CTD PMID:21420995 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of GK protein CTD PMID:16538041 perfluorododecanoic acid decreases expression ISO RGD:1344759 6480464 perfluorododecanoic acid results in decreased expression of GK mRNA CTD PMID:23567314 perfluorohexanesulfonic acid increases expression ISO RGD:1344759 6480464 perfluorohexanesulfonic acid results in increased expression of GK mRNA CTD PMID:23567314 perfluorooctane-1-sulfonic acid increases expression ISO RGD:1344759 6480464 perfluorooctane sulfonic acid results in increased expression of GK mRNA CTD PMID:23567314 perfluorooctane-1-sulfonic acid increases expression EXP 6480464 perfluorooctane sulfonic acid results in increased expression of GK mRNA CTD PMID:21723365 perfluorooctanoic acid increases expression ISO RGD:1344759 6480464 perfluorooctanoic acid results in increased expression of GK mRNA CTD PMID:21723365 , PMID:23567314 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of GK mRNA CTD PMID:21723365 , PMID:28511854 phenobarbital affects expression ISO RGD:1344759 6480464 Phenobarbital affects the expression of GK mRNA CTD PMID:19159669 phenobarbital multiple interactions ISO RGD:737445 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of GK mRNA CTD PMID:24535843 phenobarbital affects expression ISO RGD:737445 6480464 Phenobarbital affects the expression of GK mRNA CTD PMID:23091169 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of GK mRNA CTD PMID:16940010 pirinixic acid increases expression ISO RGD:737445 6480464 pirinixic acid results in increased expression of GK mRNA CTD PMID:16357043 more ... potassium dichromate increases expression ISO RGD:737445 6480464 Potassium Dichromate results in increased expression of GK mRNA CTD PMID:23608068 progesterone increases expression ISO RGD:1344759 6480464 Progesterone results in increased expression of GK mRNA CTD PMID:18070364 propamocarb decreases expression ISO RGD:737445 6480464 propamocarb results in decreased expression of GK mRNA CTD PMID:29137890 propranolol decreases activity EXP 6480464 Propranolol results in decreased activity of GK protein CTD PMID:12736183 SB 431542 multiple interactions ISO RGD:1344759 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GK mRNA CTD PMID:27188386 silicon dioxide decreases expression ISO RGD:1344759 6480464 Silicon Dioxide results in decreased expression of GK mRNA CTD PMID:25351596 sodium dichromate decreases expression EXP 6480464 sodium bichromate results in decreased expression of GK mRNA CTD PMID:25993096 sodium fluoride decreases expression ISO RGD:737445 6480464 Sodium Fluoride results in decreased expression of GK protein CTD PMID:28918527 streptozocin decreases expression EXP 6480464 Streptozocin results in decreased expression of GK mRNA CTD PMID:25905778 sulindac sulfide increases expression ISO RGD:1344759 6480464 sulindac sulfide results in increased expression of GK mRNA CTD PMID:16184548 Tesaglitazar increases expression EXP 6480464 tesaglitazar results in increased expression of GK mRNA CTD PMID:21515302 tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of GK mRNA CTD PMID:12734012 titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of GK mRNA CTD PMID:30012374 tributylstannane increases expression ISO RGD:737445 6480464 tributyltin results in increased expression of GK mRNA CTD PMID:23322813 trichloroethene increases expression ISO RGD:737445 6480464 Trichloroethylene results in increased expression of GK mRNA CTD PMID:19448997 trichostatin A affects expression ISO RGD:1344759 6480464 trichostatin A affects the expression of GK mRNA CTD PMID:28542535 troglitazone increases expression EXP 6480464 troglitazone results in increased expression of GK mRNA CTD PMID:21515302 urethane decreases expression ISO RGD:1344759 6480464 Urethane results in decreased expression of GK mRNA CTD PMID:28818685 valproic acid increases expression ISO RGD:1344759 6480464 Valproic Acid results in increased expression of GK mRNA CTD PMID:23179753 more ... valproic acid increases methylation ISO RGD:1344759 6480464 Valproic Acid results in increased methylation of GK gene CTD PMID:29501571 valproic acid decreases expression ISO RGD:1344759 6480464 Valproic Acid results in decreased expression of GK protein CTD PMID:29501571 valproic acid multiple interactions ISO RGD:1344759 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GK mRNA CTD PMID:27188386 vancomycin increases expression ISO RGD:737445 6480464 Vancomycin results in increased expression of GK mRNA CTD PMID:18930951 zinc atom increases expression EXP 6480464 Zinc deficiency results in increased expression of GK mRNA CTD PMID:12672911 , PMID:15671213 zinc(0) increases expression EXP 6480464 Zinc deficiency results in increased expression of GK mRNA CTD PMID:12672911 , PMID:15671213 zoledronic acid increases expression ISO RGD:1344759 6480464 zoledronic acid results in increased expression of GK mRNA CTD PMID:20977926
Gene-Chemical Interaction Annotations
